Letybo

Bio & Pharma Hugel resubmits application to FDA for botulinum toxin product

South Korea's biopharmaceutical company Hugel Inc., announced on Friday that it has resubmitted applications to the US Food and Drug Administration ...

Bio & Pharma Hugel accelerates European botox sales with Poland's approval

Hugel Inc., South Korea’s largest maker of botulinum toxin products used to treat overactive muscles and facial wrinkles, has won sales approv...

Bio & Pharma Medytox-Hugel dispute over botox strain intensifies with ITC probe

A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...